AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
+15.01%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.22B
AUM Growth
+$304M
(+33%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
10.27%
Top 10 Holdings %
Top 10 Hldgs %
43.34%
Holding
94
New
24
Increased
23
Reduced
14
Closed
27
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$55.8M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$53.2M |
| 3 |
Pacira BioSciences
PCRX
|
$40.8M |
| 4 |
Biogen
BIIB
|
$35.5M |
| 5 |
Burlington
BURL
|
$31.3M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$72.9M |
| 2 |
SGI
Somnigroup International Inc.
SGI
|
$34.1M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$31.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$26.1M |
| 5 |
Voyager Therapeutics
VYGR
|
$24.9M |
Sector Composition
| 1 | Healthcare | 53.85% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Consumer Staples | 10.23% |
| 4 | Industrials | 7.48% |
| 5 | Communication Services | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Kiora Pharmaceuticals
KPRX
$9.2M
| $5.43M | 0.3% |
3,299
+102
| +3% | +$168K |
|
|
PETQ
52
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $4.96M | 0.27% |
+158,000
| New | +$4.96M |
|
|
FPRX
53
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.02M | 0.22% |
+300,000
| New | +$4.02M |
|
54
Tyson Foods
TSN
$20B
| $3.61M | 0.2% |
+52,000
| New | +$3.61M |
|
55
AYTU BioPharma
AYTU
$20.2M
| $3.34M | 0.18% |
10,000
+9,500
| +1,900% | +$3.17M |
|
56
Ovid Therapeutics
OVID
$87.5M
| $3.15M | 0.17% |
1,780,000
+180,000
| +11% | +$319K |
|
57
CRISPR Therapeutics
CRSP
$4.99B
| $2.86M | 0.16% |
80,000
-92,000
| -53% | -$3.29M |
|
|
SRRA
58
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.67M | 0.15% |
39,000
-1,000
| -3% | -$68.4K |
|
|
MDGSW
59
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
| $2.04M | 0.11% |
1,285,715
| – | – |
|
|
BLPH
60
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $1.89M | 0.1% |
+193,333
| New | +$1.89M |
|
|
DYNT
61
DELISTED
Dynatronics Corp
DYNT
| $1.19M | 0.07% |
115,200
+3,000
| +3% | +$30.9K |
|
|
ROX
62
DELISTED
Castle Brands, Inc.
ROX
| $697K | 0.04% |
1,000,000
-42,000
| -4% | -$29.3K |
|
63
Cenntro
CENN
$26.7M
| $460K | 0.03% |
97
-162
| -63% | -$768K |
|
64
Moleculin Biotech
MBRX
$11.4M
| $179K | 0.01% |
+2,451
| New | +$179K |
|
65
Advance Auto Parts
AAP
$3.63B
| – | – |
-42,000
| Closed | -$6.61M |
|
66
Achieve Life Sciences
ACHV
$145M
| – | – |
-22,400
| Closed | -$542K |
|
67
Assertio
ASRT
$76.8M
| – | – |
-819,500
| Closed | -$11.8M |
|
68
Alphatec Holdings
ATEC
$2.43B
| – | – |
-3,338,414
| Closed | -$7.65M |
|
69
Citius Pharmaceuticals
CTXR
$20.9M
| – | – |
-29,537
| Closed | -$768K |
|
70
CVS Health
CVS
$93.6B
| – | – |
-158,000
| Closed | -$10.4M |
|
71
Foot Locker
FL
$2.29B
| – | – |
-212,000
| Closed | -$11.3M |
|
72
Hain Celestial
HAIN
$164M
| – | – |
0
| – | – |
|
73
Incyte
INCY
$16.9B
| – | – |
-100,000
| Closed | -$6.36M |
|
74
Marker Therapeutics
MRKR
$11.6M
| – | – |
-148,800
| Closed | -$8.26M |
|
75
Oramed Pharmaceuticals
ORMP
$91.4M
| – | – |
-542,944
| Closed | -$1.63M |
|